Department Of Hematology and Oncology
Shaheer Khan, DO
(Biography not available)

Clinical Studies Managed By This Investigator:
Condition Study Title
Cancer [ CLOSED ] A Study for Patients with Advanced Solid Tumors Using Study Drug BMS-986207
Uveal Melanoma [ CLOSED ] Safety and Efficacy Study of IMCgp100 in Patients with Previously Untreated Advanced Uveal Melanoma
Uveal Melanoma A Prospective Natural History Study in Uveal Melanoma
Solid Tumors [ CLOSED ] A Study of BA3021 in Patients with Advanced Solid Tumors (Lung Cancer, Triple Negative Breast Cancer, or Soft Tissue Sarcoma)
Melanoma [ CLOSED ] Study of Ipilimumab in Combination with Nivolumab in Subjects with High-risk Ocular Melanoma
Cancer Study of IDE196 in Patients with Solid Tumors
Cancer [ CLOSED ] Study of BA3011 in Subjects with Advanced Solid Tumors
Melanoma [ CLOSED ] IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
Sarcoma [ CLOSED ] Study of Paclitaxel With and Without Nivolumab and Nivolumab and Cabozantinib in Taxane Pretreated Subjects with Angiosarcoma
Sarcoma Study of Belinostat and Guadecitabine for Treatment of Chondrosarcoma
Cancer A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors
Cancer [ CLOSED ] Study of MPT-0118 Alone or in Combination with Keytruda in Patients with Advanced or Metastatic Cancer
Melanoma [ CLOSED ] A First-in-Human Study Using FHD-286 in Patients with Metastatic Uveal Melanoma
Cancer Study of CS5001 in Patients with Advanced Solid Tumors
Sarcoma Study of INBRX 109 in Patients with Metastatic or Inoperable Chondrosarcoma
Melanoma Study of DYP688 in Patients with Melanoma
Skin Cancer Study of RP1 in Organ Transplant Patients with Skin Cancer
Sarcoma Study of Drug - CFT8634 in Patients with Synovial Sarcoma or SMARCB1-Null Tumors